| Filed On | Filing |
|---|---|
| 16 Nov 2026 | SCHEDULE 13G |
| 16 Nov 2026 | SCHEDULE 13G |
| 16 Nov 2026 | SCHEDULE 13G |
| 13 Nov 2026 | 10-Q |
| 13 Nov 2026 | SCHEDULE 13G |
| 19 Aug 2026 | 10-Q |
| 21 Jul 2026 | SCHEDULE 13D |
| 21 Jul 2026 | SCHEDULE 13G |
| 20 Jul 2026 | SCHEDULE 13G |
| 20 Jul 2026 |
8-K: Other Events
Audited Financial Statement of Research Alliance Corporation IV: |
| 20 Jul 2026 | SCHEDULE 13G |
| 20 Jul 2026 | SCHEDULE 13G |
| 16 Jul 2026 |
Form 4: Research Alliance Holdings Iv Llc, Director
Received 275,000 shares as a grant or award ($2.75M) |
| 16 Jul 2026 |
Form 4: Hammond Matthew, Director
Received 275,000 shares as a grant or award ($2.75M) |
| 14 Jul 2026 |
8-K: Entry into a Material Definitive Agreement; Unregistered Sales of Equity Securities +3 more
This letter (this “Letter Agreement”) is being delivered to you in accordance with the Underwriting Agreement (the “Underwriting Agreement”) entered into by and between Research Alliance Corporation IV, a Cayman Islands exempted company ... |
| 13 Jul 2026 | 424B4 |
| 10 Jul 2026 | EFFECT |
| 10 Jul 2026 | CERT |
| 10 Jul 2026 | Form 3: Research Alliance Holdings Iv Llc, Director |
| 10 Jul 2026 |
Form 3: Stusnick Henry William, COO and CBO
No securities owned |
Loading...